TOKENPOST
1 min read
Add as a preferred source on Google

Health Care ETF XLV Gains 9.53% in October Amid Tech Rotation

Regeneron and Eli Lilly rose, while Illumina and Solventum declined.

By Enna Lee
Published
An unmarked medicine vial lowers a brass scale beside a silicon wafer / TokenPost.ai
An unmarked medicine vial lowers a brass scale beside a silicon wafer / TokenPost.ai

The Health Care Select Sector SPDR Fund (XLV) rose 9.53% in October as investors shifted toward defensive health care shares amid a rotation away from technology stocks.

Regeneron climbed 26.28% after results exceeded expectations and revenue grew through its collaboration with Sanofi. Eli Lilly advanced 23.28% amid strong results, a higher full-year revenue outlook and demand for Mounjaro and Zepbound.

Illumina fell 11.19% after quarterly revenue missed expectations despite a stronger-than-expected bottom line. Solventum declined 7.34%.

Enna Lee

Reporter

Enna Lee reports on investing and digital-asset markets for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…